Sickle cell disease, long ignored by drugmakers, turned out to be a perfect target for the flashy gene editing tool CRISPR. The question is, what next?
Comments
(ーー゛)
There's nothing here…
Sickle cell disease, long ignored by drugmakers, turned out to be a perfect target for the flashy gene editing tool CRISPR. The question is, what next?